Back
Lixte Biotechnology Holdings, Inc. 10K Form
Sell
30
LIXT
Lixte Biotechnology Holdings, Inc.
Last Price:
$4.06
Seasonality Move:
-9.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LIXT News And Ratings
See the #1 stock for the next 7 days that we like better than LIXT
LIXT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-926.8K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.41 |
| Price / Book: | 9.79 |
Profitability
| EPS (TTM): | -1.17590 |
|---|---|
| Net Income (TTM): | $-4.1M |
| Gross Margin: | $0 |
| Return on Equity: | -228.97% |
| Return on Assets: | -185.98% |
Lixte Biotechnology Holdings, Inc. Earnings Forecast
Key Lixte Biotechnology Holdings, Inc. Financial Ratios
-
Per Share Earnings over the last 20 years have been positive in 8 years.
Lixte Biotechnology Holdings, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LIXT |
| Website: | lixte.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 10.42 |
| Quick Ratio: | 10.25 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LIXT Technical Analysis vs Fundamental Analysis
Sell
30
Lixte Biotechnology Holdings, Inc. (LIXT)
is a Sell
Is Lixte Biotechnology Holdings, Inc. a Buy or a Sell?
-
Lixte Biotechnology Holdings, Inc. stock is rated a SellThe current Lixte Biotechnology Holdings, Inc. [LIXT] share price is $4.05. The Score for LIXT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.